1Peters PJ, Geuze HJ, Van der HA. A new model for lethal hit delivery by cytotoxic T lymphocytes [J]. Immunol Today,1990,11:28.
2毕爱华.医学免疫学 [M].北京 :人民军医出版社,1996.106-158.
3Mcmichael. Monoclonal antibody in clinical medicine [M]. Academic Press, 1982:24.
4Phillips JH,Lanier LL. Dissection of the lymphokine anti vated killer phenomenon:relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis [J]. J Exp Med, 1986, 164:814.
5Ortaldo JR, Manson A, Overton R. Lymphokine activated killer cells: analysis of progenitors and effectors [J]. J Exp Med, 1986, 164:1193.
6Yacyshyn MB, Poppema S, Berg A, et al. CD69 and HLADR activation antigens on peripheral blood lymphocyte populations in metastatic. breast and ovarian cancer patients: correlations with survival following active specific immunotherapy [J]. Int J Cancer, 1995, 61(4):470- 474.
7Hong WS, Min YI, Son YS, et al. Peripheral blood lymphocyte subsets in patients with stomach cancer [J]. J Korean Med Sci, 1995, 10(3):164- 168.
7Zhang XY, Chan WY, Whitney B M, Fan D M, Chow JH, Liu Y, Ng EK, Chung SC. T cell receptor Vbetarepertoire expression reflects gastric carcinoma progression. Clin Immunol, 2001,101:3-7.
8Yoshikawa T, Saito H, Osaki T, Matsumoto S,T sujitani S, Ikeg- uehi M. Elevated Fas expression is related to increased apoptosis of circulating CD8 + T cell in patients with gastric cancer[J] . Surg Res, 2008,148:143 - 151.
9Steinman RM, Kaplan G, Witmer MD, et al. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purifica- tion of spleen dendritic ceUs, new surface markers, and mainte- nance in vitro. J Exp Med, 1979, 149 (1): 1 -16.
10Girardi M. Immunosurveillance and immunoregulation by gam - madelta T cells [ J ] . Invest Dermatol,2006,126 ( 1 ) : 25 - 31.
